RMH Neuroscience Foundation

RMH Neuroscience Foundation Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from RMH Neuroscience Foundation, Melbourne.

Funding research at The Royal Melbourne Hospital to detect, prevent and treat brain diseases – including brain tumour, stroke, dementia, multiple sclerosis, epilepsy and movement disorders. The Royal Melbourne Hospital Neuroscience Foundation was established in 1992 to raise funds to support all forms of research and clinical activities of the Neurosciences at The Royal Melbourne Hospital. It has

developed and expanded incrementally each year to be one of the leading organisations investigating the causes, complications, treatment and prevention of brain and spinal diseases. The main areas of fundraising are
• Brain tumour
• Acoustic Neuroma
• Spinal Tumours
• Stroke
• Aneurysms
• Epilepsy
• Multiple Sclerosis
• Alzheimer's Disease
• Dementia
• Parkinson’s Disease

The Foundation direct its support to a variety of activities which include:
• provision of grants for investigator driven and independent research
• sponsoring educational development of promising researchers
• strategic facilitation of research through mentorship and the provision of research facilities and equipment.

Today marks Huntington's Victoria’s 💙   campaign - part of Huntington’s Disease Awareness Month.This initiative aims to ...
22/05/2026

Today marks Huntington's Victoria’s 💙 campaign - part of Huntington’s Disease Awareness Month.

This initiative aims to raise awareness of Huntington’s disease – a progressive neurodegenerative condition caused by a genetic mutation.

Over the past few years, our Huntington’s team has built on a range of meaningful research initiatives. What ‘started in a garage’ is now advancing into several active clinical trials, all working toward future treatments for people living with Huntington’s.

As our research grows, so does our team. Meet the HD Bunch:
🧑‍⚕️Prof Dennis Velakoulis – Head of Department
🧑‍⚕️Dr Pierre Wibawa – Consultant
🧑‍⚕️Dr Tom Riley – Consultant
👩‍🔬Anice Abin – Team Lead & Research Nurse
👩‍🔬Karen Chidgey – Research Nurse
👩‍🔬Lei Chen – Research Nurse
👩‍💼Courtney Harris – Ethics Coordinator
👨‍💼Kenny Senthuran – Research Assistant

Our team is dedicated to connecting world-class clinical trials with local patients, ensuring Australians have access to emerging and potentially life-changing therapies. With a strong focus on Huntington’s disease, our work extends across all Neuropsychiatry, including Alzheimer’s disease, Niemann-Pick Disease Type C (NPC), and prion diseases.

A special thanks to office mascot Alfie🐾 for sup-paw-ting the campaign ➡️

For National Volunteer Week, we’re highlighting a different, but equally important, kind of volunteer — our Fundraisers....
19/05/2026

For National Volunteer Week, we’re highlighting a different, but equally important, kind of volunteer — our Fundraisers.

Last week, the nurses of 4SW Neurosurgery ward held an amazing bake sale 🍰 to celebrate Neuroscience Nurses Week and Brain Tumour Awareness Month, with all proceeds donated to us.

In less than three hours, they raised an incredible $1,925 - talk about having your cake and eating it too!

A huge thank you to all the nurses who spent hours baking, preparing, and serving the crowds who came out in full force for their morning tea - some leaving with armfuls of treats to share with their teams across the hospital.

📸 ➡️



💜 Celebrating International Nurses Day and Neuroscience Nurses Week 🧠We proudly recognise the compassion, commitment, an...
12/05/2026

💜 Celebrating International Nurses Day and Neuroscience Nurses Week 🧠

We proudly recognise the compassion, commitment, and clinical excellence of our incredible research nurses.

Today, we’re shining a spotlight on Stroke Research Nurse Coordinator, Nicola Parsons.

Nikki joined The Royal Melbourne Hospital in 2017 and delivers nearly a decade of valuable expertise and enduring passion to patient-centred stroke care and clinical research.

Swipe to learn more about Nikki and her nursing journey.

Thank you to all our research nurses for making a difference in the lives of our patients, every day.



Our research goes global - and it’s our people leading the way.Last week, our clinicians and researchers were on the gro...
11/05/2026

Our research goes global - and it’s our people leading the way.

Last week, our clinicians and researchers were on the ground in the Netherlands at the 12th European Stroke Organisation Conference (ESOC), uniting with the stroke community on a world stage, exchanging data and real-world outcomes.

Presentations:
🧠 EXTEND-IA DNase: Safety and Efficacy of Recombinant Human DNase1 (Dornase Alfa) as an Adjuvant Thrombolytic in Large Vessel Ischaemic Stroke | Prof Bruce Campbell
🧠 Results of Central Imaging Adjudication from Analysis of Mechanical Thrombectomy for Large Core Ischemic Stroke (ATLAS) Collaboration: An Individual-Patient-Data Meta-Analysis of Six Randomized Controlled Trials | Prof Bruce Campbell (US collaboration)
🧠 Effect of Time to Revascularization on the Value of Bridging Thrombolytic 4.5-24h in Ischemic Stroke with Proximal Middle Cerebral Artery Occlusion in the TNK-PLUS Trial | Prof Bruce Campbell (China collaboration) + JAMA publication
🧠 DNase and Beyond: Moving Recanalization Forward | Prof Bruce Campbell
🧠 Causal inference in observational studies | Prof Leonid Churilov

Posters:
🧠 Feasibility, Safety, and Useability Assessment of the Wellumio ‘Axana’ 0.1T Portable Magnetic Resonance Imaging Device | Prof Stephen Davis & Prof Geoffrey Donnan
🧠 Clearance Deficiency of Neutrophil Extracellular Traps is an Independent Predictor for Non-Ambulatory Functional Outcome After Thrombectomy | Prof Bruce Campbell
🧠 White Matter Injury Severity is Associated with Worse Functional Outcome After Ischemic Stroke: A Graded, Tissue-Specific ADC and Kurtosis Analysis | Samantha Rivet
🧠 S*x Differences in Outcomes of Late-Window Tenecteplase Thrombolysis – A Secondary Analysis of the Trace-III Randomized Trial | Prof Bruce Campbell

This is what progress looks like - shared knowledge and a collective drive to improve outcomes for patients and families affected by stroke.

Farewell Peter, Welcome Khay-Lin!At an intimate Trustees and Friends dinner, we shared a final farewell to our Executive...
28/04/2026

Farewell Peter, Welcome Khay-Lin!

At an intimate Trustees and Friends dinner, we shared a final farewell to our Executive Officer, Peter Davis OAM, whose dedicated service and outstanding contribution to the Foundation has spanned 20 years.

Peter was honoured with the Foundation Medal, joining an elite group of recipients that includes: Inaugural Ambassador - Carrie Bickmore OAM, Friends Life Governor - Alex Tseng, and the Warren Haynes Fellowship benefactor - the late Barbara Haynes OAM.

We extend our most sincere thanks to Peter - as a leader, trusted advisor, problem-solver, coach, gentleman, and friend.

At the same time, we warmly welcome Dr Khay-Lin Teoh as our new Executive Officer.

Khay-Lin brings a valuable blend of scientific research and business expertise, with a PhD in medicine, MBA, and membership of the Australian Institute of Company Directors (AICD). He is committed to working within an organisation that delivers a meaningful benefit to society, underpinned by a culture of excellence and innovation.

On a personal side - in his Chinese dialect, the name Khay-Lin means ‘Aspiring to Humanity’ - a value that Khay-Lin tries to embody. He is also a dedicated Kendo (Japanese fencing) practitioner, which reflects his commitment to discipline the human character through the pursuit of the art.

With his keen strategic insight and values-driven leadership, we are excited for the impact Khay-Lin will bring to the Foundation.

Congratulations to Dr Vivien Li on her significant progress in multiple sclerosis research and clinical activities, foll...
21/04/2026

Congratulations to Dr Vivien Li on her significant progress in multiple sclerosis research and clinical activities, following the completion of her second year of the Warren Haynes Fellowship.

4 x Research Projects
🧠 Advancing clinical translation of tolerogenic dendritic cells for treatment of MS
🧠 PRIMeS (Progression in Multiple Sclerosis)
🧠 INTREPID 7T MRI study
🧠 Perforin in MS

2 x Poster Presentations
🧠 Identifying antigenic epitopes for tolerogenic therapy in multiple sclerosis. ECTRIMS 2025.
🧠 Comparing MS disease activity during treatment switch on 3- and 7-Tesla MRI. MS Australia Progress in Research conference 2025.

6 x Publications
🧠 🧠 🧠 🧠 🧠 🧠

Read Dr Li’s research fellowship report:
🔗 https://tinyurl.com/rmhnfwhf

The Warren Haynes Fellowship provides select clinical researchers the opportunity to undertake substantial research programs at The Royal Melbourne Hospital, in conjunction with a professional clinical career within the neurosciences.

We are proud to deliver this prestigious fellowship, made possible through the generosity of its sole benefactor, the late Barbara Haynes OAM. This legacy from the Haynes family will continue to benefit our promising clinical researchers for many years to come.

World Parkinson's Day aims to raise awareness, improve understanding, and promote advocacy for Parkinson's disease - a p...
13/04/2026

World Parkinson's Day aims to raise awareness, improve understanding, and promote advocacy for Parkinson's disease - a progressive neurological condition and currently the fastest-growing neurological disorder worldwide.

This year saw the introduction of a global moment, Spark the Night, encouraging landmarks and public spaces to be illuminated in bright blue, to shine a light on Parkinson’s awareness - because ‘most people still don’t see it coming’.

While we didn’t have the means to illuminate the whole hospital, we did mark the occasion by lighting up the meeting room with a blue morning tea. Thank you to Joe at AbbVie for sponsoring the catering, and our researcher Bec for organising.

Our Movement Disorders team, in conjunction with our Neurosurgery team, are currently progressing one of our newest clinical trials – exPDite: A study to assess Midbrain Dopaminergic Neuronal Cell Therapy to restore motor function for participants with Parkinson's disease. We are proud to be the second site outside the United States to commence this promising research, and look forward to sharing exciting future updates.

You can support Parkinson’s research by donating:
🔗neuroscience.org.au/donate

Today is World Health Day, highlighting the 2026 theme “Together for health. Stand with science.”To mark the occasion, w...
07/04/2026

Today is World Health Day, highlighting the 2026 theme “Together for health. Stand with science.”

To mark the occasion, we’re sharing photos from our Broken Brains Lunch held on Friday 20 March, hosted by Prof Kate Drummond, where a fabulous time was had by all.

A huge thank you to our Ambassador Jamila Rizvi and co-author Rosie Waterland for sharing their tough yet deeply relatable stories, their struggles with brain health, that created a powerful sense of connection and empathy with our audience.

We were delighted to host this special, intimate event and are grateful to everyone who supported it.

More to come!

We are thrilled to announce the recipients of our 2026 Research Grants!Congratulations:🧠 Dr Tom Richardson – Stroke | Ea...
31/03/2026

We are thrilled to announce the recipients of our 2026 Research Grants!

Congratulations:
🧠 Dr Tom Richardson – Stroke | Early identification of delayed cerebral ischaemia in aneurysmal subarachnoid
haemorrhage
🧠 Dr Yeung-Ae Park – Brain tumour | Decoding Dopamine Agonist Resistance in Prolactinomas: A Spatial Multi-Omic Study
🧠 Dr Sarah Thomas – Stroke | Radiomic analysis using photon-counting computer tomography and histopathologic
correlation of acute stroke thrombi: A pathway to precision diagnostics
🧠 A/Prof Andrew Morokoff – Brain tumour | A ddPCR-based ctDNA Liquid Biopsy for Glioma (on-going)
🧠 Dr Chloe Mutimer – Stroke | Imaging and Biomarker Signatures of Inflammation in Cerebral Amyloid Angiopathy

Read about these exciting projects on our website:
neuroscience.org.au/research-funding

💜 Today is Purple Day for World Epilepsy Day – a global initiative to raise awareness, reduce stigma, and highlight the ...
26/03/2026

💜 Today is Purple Day for World Epilepsy Day – a global initiative to raise awareness, reduce stigma, and highlight the needs of the more than 50 million people living with epilepsy worldwide.

We marked the day with a big team photo, a splash of purple, and some delicious purple cupcakes, with thanks to The Cupcake Queens.

This photo was taken during the weekly VEM Meeting. Video EEG monitoring (VEM) is a specialised diagnostic test that records a person's brainwave activity (EEG) alongside their physical behaviour (video) over an extended period – primarily used to diagnose and treat epilepsy.

💜 You can support epilepsy research:
neuroscience.org.au/donate

Address

Melbourne, VIC

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when RMH Neuroscience Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

Share